Amarin Technologies S.A. (Amarin) operates as a well-established Argentinean company located in Buenos Aires, Argentina, focusing specifically on the development of topical and transdermal pharmaceutical products through the utilization of proprietary drug delivery technologies and expertise. The R&D team of Amarin has been active since the early 1986 and has successfully brought innovative formulations and generic versions of well-established drugs to various markets worldwide, including EU, Latam and the US (Fentanyl, Rivastigmine, Buprenorphine, and Diclofenac). Helm AG, a Hamburg-based company, became a strategic shareholder in Amarin in September 2010.
Products & Services
Bioavailability & Bioequivalence Studies
Buprenorphine Patch
Contract Manufacturing For Gel
Contract Manufacturing For Transdermal Patch
Sites
Amarin Technologies S.A.
Country
ArgentinaCity
Buenos Aires
Address
Sánchez 2043/2045, C1416 BQG